Being an Ohio based, Cleveland sports fan has toughened my heart to the bitter disappointments of holding Vical stock. It's always great in animals but VJ can never get it out the pipe and into market for humans. There is always a huge unmet need for whatever Vical is working on, but Vijay can't get that elusive partnership that would get Cymvectin moving and create some value for the stock.
Now comes Herpes. The test structure was bad but the results for humans they can see with their eyes and affects their mindset and sexual attractiveness are holding up over time. It amazes me Vijay didn't throw in the towel on this but maybe Vical will pull one out like the Cav's did. It would be just as amazing!